| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18832524 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 100 journal articles in the PubMed database | Email to a friend | | |
| Fidder HH, Schnitzler F, Ferrante M, et al.
Long-Term Safety of Infliximab for the treatment of Inflammatory Bowel Disease: A Single Center Cohort Study. [JOURNAL ARTICLE]
Gut 2008 Oct 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Wahn U, Bos JD, Goodfield M, et al.
Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Pediatrics 2002 Jul; 110(1 Pt 1):e2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Caspersen S, Elkjaer M, Riis L, et al.
Infliximab for Inflammatory Bowel Disease in Denmark 1999-2005: Clinical Outcome and Follow-Up Evaluation of Malignancy and Mortality. [JOURNAL ARTICLE]
Clin Gastroenterol Hepatol 2008 Oct 8.
Abstract | Full Citation | Find Related Articles | | Seiderer J, Göke B, Ochsenkühn T
Safety aspects of infliximab in inflammatory bowel disease patients. A retrospective cohort study in 100 patients of a German University Hospital. [Journal Article]
Digestion 2004; 70(1):3-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Woolacott N, Bravo Vergel Y, Hawkins N, et al.
Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. [JOURNAL ARTICLE]
Health Technol Assess 2006 Sep; 10(31):1-258.
Abstract | Full Citation | | Smith CH, Jackson K, Bashir SJ, et al.
Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study. [JOURNAL ARTICLE]
Br J Dermatol 2006 Jul; 155(1):160-169.
Abstract | Full Citation | | Ljung T, Karlén P, Schmidt D, et al.
Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County. [Journal Article, Multicenter Study]
Gut 2004 Jun; 53(6):849-53.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Mow WS, Abreu-Martin MT, Papadakis KA, et al.
High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy. [Journal Article]
Clin Gastroenterol Hepatol 2004 Apr; 2(4):309-13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Baeten D, Kruithof E, Van den Bosch F, et al.
Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease? [Case Reports, Journal Article]
Ann Rheum Dis 2003 Sep; 62(9):829-34.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
